Skip to main content
Evidence Based Longevity (EBL)Check what I take
← All protocols
D

Protocol

Cauliflower and other cruciferous vegetables for cancer prevention

No randomized human trial has tested eating cauliflower, broccoli, cabbage or other cruciferous vegetables against cancer.

Grade D, not yet tested: no human randomized trial has been run. This D records missing trials, not a finding that it does not work. How to read a grade →

Compare this record with another, side by side →

At a glance

In plain words

People often hear that broccoli, cauliflower and cabbage prevent cancer. No trial has tested that by assigning people to eat them and counting cancers. Short studies show changes in urine and blood, which is not the same thing. The D here means not yet tested. It does not mean these vegetables are bad for you.

The letter, taken apart
What was measured
No trial has counted cancers. The closest study measured a urine marker of DNA damage for one week.
How big
Not tested for cancer in trials that assign people to eat these vegetables. In the marker study, Brussels sprouts lowered the urine marker in four of five men and not in women.Read from the summary of PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 9103270.
Who it applies to
No population has been tested for cancer outcomes.
Safety
None identified.
The record in one view
Compared with
Glucosinolate-free vegetables, in that 10-person marker study.
Certainty
Grade D, resting on: No randomized human trial of the claim; observational Research that watches what people already do rather than assigning a treatment. It can show that two things travel together, not that one causes the other. and marker studies only.
What would change this grade
Could rise to C with: Randomized trial of increased cruciferous vegetable intake. Who: Adults at raised risk of colorectal or other cancers. Measured: Adenoma recurrence or cancer incidence. Length: At least 3 years.
Cost
No price recorded yet.
Sources
2 studies cited on this record, listed under Sources.
For clinicians
A one-page summary of this record that prints with a clinician's name and practice, folds to a plain-language patient handout, and gives a chart note to paste into the patient record: Printable summary and chart note.
Food
DHard clinical endpoint · Not yet tested Grade D

No randomized human trial has tested eating cauliflower, broccoli, cabbage or other cruciferous vegetables against cancer. The trials that exist measure urine and blood markers over days to months, and a large trial of a whole high-vegetable diet after breast cancer (WHEL) tested the diet, not cruciferous vegetables alone. The D means the claim is untested, not that these vegetables are unhealthy.

Why this letter

Why this gradeGrade D, not yet tested. The reasoning, and what the grade does not cover.
Why this grade

Grade D on Route 1 No human randomized trial has been run, so the record rests on animal or mechanistic evidence only. One of the two routes to the lowest letter on EBL's scale. for cancer prevention: not tested in human randomized trials. EBL's stored PubMed search found no randomized trial that assigned people to eat cruciferous vegetables and counted cancers; the 22 records it returns are marker studies, observational analyses, a small dietary pilot and reports on whole-diet trials. This grade applies to every untested intervention the same way, foods included (EBL rule, November 2026). It is not a judgment that these vegetables are unhealthy: it records that the cancer claim made for them has not been put to a randomized test.

WHAT THIS GRADE DOES NOT COVERbroccoli sprout extract and sulforaphane, which have their own record with randomized trials, and cruciferous vegetables as part of whole diets such as the Mediterranean diet, graded on those records.

A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →

Who responds: this record's trial reading reports no subgroup that identifies who responds.

Evidence notes:

Endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. graded: Cancer incidence (hard)

Last reviewed: November 2026

Evidence wanted

The trial that would change this grade.

DesignRandomized trial of increased cruciferous vegetable intake
PopulationAdults at raised risk of colorectal or other cancers
EndpointAdenoma recurrence or cancer incidence
DurationAt least 3 years

A positive trial of this shape would move this entry to C.

Why the current trials fall short

Even an adenoma-recurrence trial would move this off Route 1.

Clinical trials

ClinicalTrials.gov, the public registry run by the U.S. National Library of Medicine, lists studies that are recruiting volunteers. The link below searches it for Brassicaceae among studies recruiting now. EBL has no relationship with any listed study and receives no payment for this link.

Search recruiting studies of Brassicaceae on ClinicalTrials.gov

Dose, form and timing

What to track

Nothing to track; the claim has not been tested.

Safety

Safety evidence, by strength

No safety data. Each caution on this record, sorted by what it rests on.

Documented in human studies
Cautions resting on what randomized trials or large studies found in people.

None recorded.

Suspected from case reports
Harms reported in individual patients or uncontrolled observations, not confirmed by a trial.

None recorded.

Mechanistic only
Cautions reasoned from how it works, with no human harm data behind them.

None recorded.

Population cautions
Groups in whom it has not been studied, so its safety there is unknown.

None recorded.

No safety data

No safety data: EBL has found no trial or report of harm for this record. That is an absence of evidence, not a finding of safety.

Grade history

How this letter has changedLatest: No. 461 · November 2026 · First graded.
Grade history
No. 461 · November 2026 · First graded
Cauliflower and other cruciferous vegetables for cancer prevention enters the food section: Grade D

New record in the food section. No randomized human trial has tested eating cauliflower, broccoli, cabbage or other cruciferous vegetables against cancer. The trials that exist measure urine and blood markers over days to months, and a large trial of a whole high-vegetable diet after breast cancer (WHEL) tested the diet, not cruciferous vegetables alone. The D means the claim is untested, not that these vegetables are unhealthy.PMID 9103270 PMID 17516858

Every change to a letter on this site is dated and published. The full evidence log →

Sources

How this record was checked
Citations
Every paper cited on this page is matched to its PubMed record on every build.
Retractions
None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
Read against the papers
November 2026. By a language model (AI-assisted reading), not yet reviewed by a clinician.
Outside review
Not yet done. No reviewer outside EBL has checked this record.

What each of these checks can and cannot show: evidence integrity.

The evidence, in fullTwo papers, each linked to its PubMed record.
The evidence

No qualifying randomized trial. The stored PubMed search for randomized trials of cruciferous vegetables with cancer outcomes returned 22 records in November 2026: marker studies (urinary metabolites, DNA damage, enzyme activity), a sulforaphane extract trial in former smokers, a small dietary pilot in bladder cancer, observational cohort analyses, and a report on WHEL, which tested a whole high-vegetable diet. Broccoli sprout extracts and sulforaphane are graded on their own record. Context only, not evidence for the claim: Verhagen et al. (Cancer Lett, 1997; PMID 9103270), a 10-person crossover A trial design in which each participant receives both the treatment and the comparison, one after the other, and serves as their own control. study in which Brussels sprouts for 1 week lowered a urinary DNA-damage marker in four of five men and not in women; Thomson et al. (Nutr Cancer, 2007; PMID 17516858), cruciferous intake within WHEL, a whole high-vegetable diet trial in 1,156 breast cancer survivors.

How EBL searched for the trials (1 search)

The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.

Searched PubMed in November 2026. 22 records screened, 0 eligible for the graded claim.
Query: (cruciferous[tiab] OR cauliflower[tiab] OR broccoli[tiab] OR cabbage[tiab] OR "brassica vegetable*"[tiab]) AND randomized controlled trial[pt] AND ("cancer incidence"[tiab] OR "cancer risk"[tiab] OR "cancer prevention"[tiab] OR adenoma*[tiab] OR "cancer mortality"[tiab])
All 22 records screened by title; none is a randomized trial of cruciferous vegetables with a cancer outcome.
PubMed watch: does a new study change the grade? (nothing new)

No new paper matching the searches behind this grade has been added to PubMed since November 2026.

Last run November 2026. A letter on EBL moves only after a logged review. A new paper never moves a letter by arriving: it is read, the answer is written here, and any change to the letter is published in the evidence log.

Who paid for these trials

For each trial behind a letter on this page, the funding its PubMed record lists. "No funder" means PubMed lists none, not that the trial had no funding.

  • Verhagen et al., 1997, Cancer Lett (PMID 9103270): PubMed lists no funder for this trial.
  • Thomson et al., 2007, Nutr Cancer (PMID 17516858): PubMed lists funding from US National Institutes of Health (National Cancer Institute); US National Institutes of Health (National Center for Research Resources).

Disclosure

Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.

Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy

© Evidence Based Longevity, Inc. All rights reserved

Medical disclaimer

These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.

Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →

Build 9b19d78, November 2026